The medical technology industry is highly competitive and continues to evolve, with success measured by the development of innovative products and the value brought to stakeholders. The firm is committed to developing new technologies and providing innovative patient care, which underscores the importance of mobilizing and deploying IT-based resources in combination with leveraging the value of other resources and capabilities. In 2016, the firm invested 15.0% of its net sales in research and development, reflecting a focus on enhancing operational efficiency and supporting business needs through technology deployment. The firm’s IT capabilities represent the application of physical or intangible IT resources such as technology, knowledge, practices, relationships, management skills, and business process understanding to further organizational goals. The healthcare environment presents opportunities and challenges that necessitate a focus on innovation and technology functionalities to maintain competitive advantage. The firm has received various FDA approvals for new technologies, indicating a commitment to advancing its technology portfolio and enhancing its market responsiveness. Additionally, the acquisition of Valtech is aimed at integrating new capabilities into the existing technology infrastructure, which is essential for transforming care and improving firm performance. The firm’s strategic resource allocation reflects a focus on actionable investments that enhance operational flexibility and support business transformation. The emphasis on information management capability highlights the ability to provide data and information to users with appropriate levels of accuracy, timeliness, reliability, security, confidentiality, connectivity, and access. This capability is crucial for tailoring responses to changing business needs and directions, thereby enhancing organizational effectiveness. The firm’s investments in research and development and the strategic management of its technology resources are indicative of a proactive approach to navigating market dynamics and external influences. The focus on developing innovative products and defending intellectual property is essential for maintaining a competitive position in the market. The firm’s operational decisions are influenced by the need for effective IT governance and the integration of technology capabilities into its business processes. The commitment to generating robust clinical, economic, and quality of life evidence is aligned with the goal of encouraging the adoption of innovative new medical therapies that demonstrate superior outcomes, thereby enhancing customer value and organizational performance. The firm’s ability to adapt to environmental factors and market restructuring is critical for sustaining its competitive positioning and achieving performance excellence in a rapidly changing healthcare landscape.